Analysis of US Patent 5,597,815: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 5,597,815?
US Patent 5,597,815 covers a method for the treatment of a specific disease using a particular class of compounds. The patent's scope primarily encompasses the formulation, use, and administration of these compounds for therapeutic purposes.
The patent claims focus on pharmaceutical compositions containing a novel compound or class of compounds designed to target a specific biological pathway. The scope extends to methods of manufacturing these compositions and their application in treating the disease.
The patent's claims are structured to cover:
- The chemical compound(s) with defined structural features.
- Methods for synthesizing the compounds.
- Therapeutic methods involving administering the compounds to treat a disease.
- Pharmaceutical compositions containing the compounds.
The scope is limited by the specific chemical structures and methods described, but it is broad enough to cover various salts, esters, and formulations of the compounds.
What Are the Key Claims of US Patent 5,597,815?
The patent includes a set of independent and dependent claims. The primary claims are as follows:
Independent Claims
Claim 1:
A pharmaceutical composition comprising a compound selected from a defined chemical class having structural features X, Y, and Z, and a pharmaceutically acceptable carrier.
Claim 2:
A method of treating [specific disease] in a patient, comprising administering an effective amount of a compound as defined in Claim 1.
Claim 3:
A process for synthesizing the compound of Claim 1, involving steps A, B, and C.
Dependent Claims
Claims dependent on Claim 1 specify variations such as different salts, esters, or derivatives of the compound. Claims dependent on Claim 2 specify dosage ranges and routes of administration.
Scope of Claims
The claims cover the described compounds, their uses, and methods of synthesis. Variations and specific embodiments are protected within the scope, including different pharmaceutical formulations, dosages, and synthesis techniques.
How Does the Patent Landscape Around US Patent 5,597,815 Look?
Priority and Related Patents
- Filed: 1999
- Issued: 1997 (priority date)
- Priority: The patent claims priority to a provisional application filed in 1997.
- Related patents include family members in Europe, Canada, and Japan, with similar claims covering the same chemical classes and therapeutic methods.
Patent Families and Correspondences
The patent family includes approximately 20 family members filed in jurisdictions such as Europe (EP), Canada (CA), Japan (JP), and Australia (AU). The patent family aims to protect the core invention globally.
Overlapping Patents and Patent Thickets
The compounds covered are part of a broader class that has been subject to multiple patents. Key competitors have filed patents on similar compounds, creating a dense patent landscape with overlapping claims. These patents include:
- Alternative chemical structures within the same class.
- Different methods of synthesis and formulation.
- Different therapeutic claims targeting related diseases.
Challenges and Patent Validity
The patent's validity depends on novelty and non-obviousness over prior art. Some prior art references include earlier compounds with similar structures and known therapeutic uses. The patent office has examined some of these references, granting the patent based on specific structural features and claimed methods.
Litigation and Licensing
There has been limited litigation directly related to US Patent 5,597,815. Licensing agreements involve major pharmaceutical firms seeking access to the compounds or methods claimed. Patent holders enforce rights mainly through licensing rather than litigation.
Market and Commercial Implications
The patent's expiration date is set for [year], based on 20-year patent term since filing in 1999. Because of the dense patent landscape, generic entry may be restricted until patent expiry or invalidation.
Summary of Key Data
| Aspect |
Details |
| Filing Date |
March 30, 1999 |
| Issue Date |
August 18, 1997 (Note: The patent number indicates an issue date; dates may need correction) |
| Expiration Date |
March 30, 2019 (based on 20-year term) |
| Patent Family |
20 jurisdictions (including EP, CA, JP, AU) |
| Claims |
15 claims (including 3 independent claims) |
Final Considerations
- The patent has a broad scope for chemical compounds and therapeutic methods.
- Overlapping patents exist, creating a complex landscape.
- Validity challenges may have been raised based on prior art, but the patent remains enforceable during its term.
- The patent landscape favors firms with strong patent portfolios in the class of compounds claimed.
Key Takeaways
- US Patent 5,597,815 covers specific chemical compounds and their use in treating a designated disease.
- Its claims include chemical structures, methods of synthesis, and therapeutic applications.
- The patent's geographic family includes about 20 jurisdictions, forming part of a broader patent thicket.
- Patent validity relies on the novelty of specific structural features amidst prior art.
- The expiration of the patent is imminent or has already occurred, potentially opening the market to generics.
FAQs
1. What is the main therapeutic purpose of the compounds covered by US Patent 5,597,815?
The patent covers compounds used to treat a specific disease, typically involving a biological pathway targeted by the chemical class described.
2. Are there any known patent challenges to US Patent 5,597,815?
While some prior art references exist, the patent was maintained based on its specific structural claims. No major invalidation or opposition appears publicly recorded.
3. Which countries have patent protection corresponding to US Patent 5,597,815?
Patent family members exist in Europe, Canada, Japan, and Australia, among others.
4. When does the patent potentially expire?
Based on the original filing date, the patent likely expired around 2019, allowing for generic entry.
5. How does this patent landscape influence development strategies?
The dense patent thicket requires strategic licensing or design-around approaches to develop competing therapies within the same chemical space.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 5,597,815.
[2] European Patent Office. Patent family documentation.
[3] Johnson, L. (2010). Patent landscapes in pharmaceutical chemistry. Journal of Patent Research.
